SA

Semim Akhtar

Active Director Director DIN 11034201
DIN 11034201 First appointment Apr 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Apr 2025
Shareholding value Locked Premium profile

About Semim Akhtar

Semim Akhtar has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Prunes Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11034201
Primary Designation Director
First Appointment 03 Apr 2025
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Director 03 Apr 2025 2025 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Prunes Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Semim Akhtar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Semim Akhtar

Semim Akhtar has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Prunes Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Semim Akhtar is associated with 1 company as Director.

Semim Akhtar has expertise in General Business.

Semim Akhtar has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available